What kind of company is sirnaomics? Sirnaomics, Inc. operates as a biopharmaceutical company. The Company develops therapeutics for ocular neovascularization diseases. Sirnaomics serves customers in the United States. NO. OF EMPLOYEESHow much money has sirnaomics raised in 2020? Sirnaomics's latest funding round in October 2020 was reported to be $105 m. In total, Sirnaomics has raised $162 m Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.Is sirnaomics stp705 effective for squamous cell cancer? Sirnaomics Doses First Patient in Phase 2b Study of STP705 for Treatment of Squamous Cell Skin Cancer Company Expects to Report Interim Clinical Data of the Phase 2 in Second Half of... READ MORE June 24, 2021
Before you can login, you must activate your account with the code sent to your email address. If you did not receive this email, please check your junk/spam folder.
Sirnaomics Ltd. ("Sirnaomics" or "Company", stock code: 2257.HK)is an RNA therapeutics biopharmaceutical company with product candidates in pre-clinical and clinical stages that focuses on the